VBI Vaccines Balance Sheet Health
Financial Health criteria checks 2/6
VBI Vaccines has a total shareholder equity of $19.9M and total debt of $50.3M, which brings its debt-to-equity ratio to 252.9%. Its total assets and total liabilities are $100.8M and $80.9M respectively.
Key information
252.9%
Debt to equity ratio
US$50.30m
Debt
Interest coverage ratio | n/a |
Cash | US$35.45m |
Equity | US$19.89m |
Total liabilities | US$80.90m |
Total assets | US$100.78m |
Recent financial health updates
Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?
Oct 06VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?
Jul 08Recent updates
VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook
Sep 22VBI Vaccines gets up to $100M debt funding from K2 HealthVentures
Sep 15Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe
Sep 08VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings
Aug 26VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis
Jun 17Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24VBI Vaccines: Hepatitis Vaccine Approval Can Be A Catalyst For >$1bn Valuation
Oct 31Is VBI Vaccines (NASDAQ:VBIV) Weighed On By Its Debt Load?
Oct 06VBI Vaccines: Turning My Focus To VBI-1901
Jul 15VBI Vaccines (NASDAQ:VBIV) Has Debt But No Earnings; Should You Worry?
Jul 08VBI Vaccines shares rise after FDA grants VBI-1901 'fast track' status
Jun 08The CEO Of VBI Vaccines Inc. (NASDAQ:VBIV) Might See A Pay Rise On The Horizon
Jun 03VBI Vaccines EPS misses by $0.01, misses on revenue
May 10VBI Vaccines reports preclinical VBI-2902 data in COVID-19
Apr 28Market Sentiment Around Loss-Making VBI Vaccines Inc. (NASDAQ:VBIV)
Mar 30Financial Position Analysis
Short Term Liabilities: VBIV's short term assets ($50.1M) do not cover its short term liabilities ($77.2M).
Long Term Liabilities: VBIV's short term assets ($50.1M) exceed its long term liabilities ($3.7M).
Debt to Equity History and Analysis
Debt Level: VBIV's net debt to equity ratio (74.7%) is considered high.
Reducing Debt: VBIV's debt to equity ratio has increased from 17.7% to 252.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VBIV has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VBIV has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 11.5% each year.